High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison (1985)

Peer-Reviewed Study · Charles G. Moertel, Thomas R. Fleming, Edward T. Creagan, Joseph Rubin, Michael J. O'Connell, M. M. Ames · January 17, 1985

Charles G. Moertel et al., 1985-01-17: Randomised double-blind trial in 100 patients with advanced colorectal cancer and no prior cytotoxic treatment, comparing 10 g/day vitamin C with placebo; no advantage in time to progression or survival and no objective responses.

Vitamin C therapy showed no advantage over placebo therapy with regard to either the interval between the beginning of treatment and disease progression or patient survival.

Abstract, unpaginated web record

Charles G. Moertel et al., 1985-01-17: Randomised double-blind trial in 100 patients with advanced colorectal cancer and no prior cytotoxic treatment, comparing 10 g/day vitamin C with placebo; no advantage in time to progression or survival and no objective responses. Designed specifically to answer the Cameron-Pauling criticism that earlier negative trials used previously treated patients. Comparator: placebo, randomised, double-blind. Maker: generic ascorbic acid. Funder/conflicts: not stated in the abstract. Conclusion quoted: high-dose vitamin C 'is not effective against advanced malignant disease regardless of whether the patient has had any prior chemotherapy.' Study type: randomized trial.